{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:04:47Z","timestamp":1793941487454,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"University College London Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204841\/Z\/16\/Z"],"award-info":[{"award-number":["204841\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","award":["17GRO-PG36-0168"],"award-info":[{"award-number":["17GRO-PG36-0168"]}],"id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omtn.2020.05.029","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T20:26:13Z","timestamp":1591043173000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD"],"prefix":"10.1016","volume":"21","author":[{"given":"Sara","family":"Aguti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Bolduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Ala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Turmaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten G.","family":"B\u00f6nnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pathol Sect","key":"10.1016\/j.omtn.2020.05.029_bib1","first-page":"157","article-title":"A Case of Congenital Defect of the Muscular System (Dystrophia muscularis congenita) and its Association with Congenital Talipes equino-varus","volume":"1","author":"Howard","year":"1908","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.omtn.2020.05.029_bib2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/hmg\/5.7.1043","article-title":"Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37","volume":"5","author":"Speer","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2020.05.029_bib3","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1073\/pnas.121027598","article-title":"Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI","volume":"98","author":"Camacho Vanegas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2020.05.029_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.nmd.2012.01.010","article-title":"Relative frequency of congenital muscular dystrophy subtypes: analysis of the UK diagnostic service 2001-2008","volume":"22","author":"Clement","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2020.05.029_bib5","first-page":"435","article-title":"Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen","volume":"42","author":"Weil","year":"1988","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2020.05.029_bib6","doi-asserted-by":"crossref","first-page":"15349","DOI":"10.1016\/S0021-9258(18)55398-9","article-title":"Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth","volume":"265","author":"Prockop","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2020.05.029_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2011.81","article-title":"The collagen VI-related myopathies: muscle meets its matrix","volume":"7","author":"B\u00f6nnemann","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtn.2020.05.029_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1083\/jcb.102.3.703","article-title":"Molecular assembly, secretion, and matrix deposition of type VI collagen","volume":"102","author":"Engvall","year":"1986","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2020.05.029_bib9","first-page":"3525","article-title":"Collagen VI at a glance","volume":"128","author":"Cescon","year":"2015","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtn.2020.05.029_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-2836(03)00585-0","article-title":"The supramolecular organization of collagen VI microfibrils","volume":"330","author":"Baldock","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtn.2020.05.029_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.actbio.2016.12.023","article-title":"Defining the hierarchical organisation of collagen VI microfibrils at nanometre to micrometre length scales","volume":"52","author":"Godwin","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.omtn.2020.05.029_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.matbio.2017.12.008","article-title":"Collagen VI disorders: Insights on form and function in the extracellular matrix and beyond","volume":"71\u201372","author":"Lamand\u00e9","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omtn.2020.05.029_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/nen.0b013e3181634ef7","article-title":"Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem","volume":"67","author":"Zou","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtn.2020.05.029_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02864097","article-title":"Kongenitale, atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskul\u00e4ren Systems","volume":"126","author":"Ullrich","year":"1930","journal-title":"Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie."},{"key":"10.1016\/j.omtn.2020.05.029_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1212\/WNL.0b013e3181aae851","article-title":"Natural history of Ullrich congenital muscular dystrophy","volume":"73","author":"Nadeau","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2020.05.029_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jmg.2002.002311","article-title":"Collagen VI related muscle disorders","volume":"42","author":"Lampe","year":"2005","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtn.2020.05.029_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-08-045031-5.00005-0","article-title":"The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy","volume":"101","author":"B\u00f6nnemann","year":"2011","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.omtn.2020.05.029_bib18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1086\/340608","article-title":"Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy","volume":"70","author":"Demir","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2020.05.029_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/377107","article-title":"New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype","volume":"73","author":"Pan","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2020.05.029_bib20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.20586","article-title":"Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy","volume":"58","author":"Giusti","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2020.05.029_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/hmg\/ddi025","article-title":"Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy","volume":"14","author":"Baker","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2020.05.029_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2044-5040-1-30","article-title":"ColVI myopathies: where do we stand, where do we go?","volume":"1","author":"Allamand","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtn.2020.05.029_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ana.1120","article-title":"Frameshift mutation in the collagen VI gene causes Ullrich\u2019s disease","volume":"50","author":"Higuchi","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2020.05.029_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/01.WNL.0000113023.84421.00","article-title":"Ullrich disease due to deficiency of collagen VI in the sarcolemma","volume":"62","author":"Ishikawa","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2020.05.029_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp-2013-307052","article-title":"Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s)","volume":"86","author":"Yonekawa","year":"2015","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.omtn.2020.05.029_bib26","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1038\/mtna.2013.74","article-title":"siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy","volume":"3","author":"Bolduc","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2020.05.029_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.omtn.2017.07.006","article-title":"Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy","volume":"8","author":"Marrosu","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2020.05.029_bib28","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1038\/mtna.2014.22","article-title":"Allele-specific Gene Silencing of Mutant mRNA Restores Cellular Function in Ullrich Congenital Muscular Dystrophy Fibroblasts","volume":"3","author":"Noguchi","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2020.05.029_bib29","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1089\/hum.2012.109","article-title":"Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy","volume":"23","author":"Gualandi","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2020.05.029_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.22283","article-title":"Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy","volume":"69","author":"Foley","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2020.05.029_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.nmd.2007.03.017","article-title":"Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families","volume":"17","author":"Peat","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2020.05.029_bib32","doi-asserted-by":"crossref","first-page":"124403","DOI":"10.1172\/jci.insight.124403","article-title":"A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies","volume":"4","author":"Bolduc","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2020.05.029_bib33","doi-asserted-by":"crossref","first-page":"eaal5209","DOI":"10.1126\/scitranslmed.aal5209","article-title":"Improving genetic diagnosis in Mendelian disease with transcriptome sequencing","volume":"9","author":"Cummings","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2020.05.029_bib34","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2020.05.029_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2020.05.029_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2020.05.029_bib37","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/nar\/gkp841","article-title":"Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents","volume":"38","author":"Stein","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2020.05.029_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2015.04.005","article-title":"Cellular uptake and intracellular trafficking of oligonucleotides","volume":"87","author":"Juliano","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2020.05.029_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-61779-424-7_25","article-title":"Silencing of gene expression by gymnotic delivery of antisense oligonucleotides","volume":"815","author":"Soifer","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2020.05.029_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-61779-767-5_8","article-title":"Overview on AON design","volume":"867","author":"Aartsma-Rus","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2020.05.029_bib41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic Antisense Oligonucleotides Are Coming of Age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omtn.2020.05.029_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/humu.22691","article-title":"Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability","volume":"36","author":"Donkervoort","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2020.05.029_bib43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.nmd.2006.07.015","article-title":"A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14\u00a0Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations","volume":"16","author":"Jimenez-Mallebrera","year":"2006","journal-title":"Neuromuscul. Disord."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253120301554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253120301554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:26:17Z","timestamp":1762601177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253120301554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":43,"alternative-id":["S2162253120301554"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2020.05.029","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2020.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}